melatonin has been researched along with Diffuse Myofascial Pain Syndrome in 26 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Melatonin can improve sleep quality, pain and pain threshold." | 9.19 | Melatonin analgesia is associated with improvement of the descending endogenous pain-modulating system in fibromyalgia: a phase II, randomized, double-dummy, controlled trial. ( Caumo, W; de Souza, IC; de Zanette, SA; Deitos, A; Laste, G; Machado, CB; Rozisky, JR; Schwertner, A; Torres, IL; Vercelino, R; Xavier, F, 2014) |
| "The aim of the study was to determine the possible effect of melatonin treatment on disturbed sleep, fatigue and pain symptoms observed in fibromyalgia (FM) patients." | 9.09 | The effect of melatonin in patients with fibromyalgia: a pilot study. ( Arias, MA; Brusco, LI; Cardinalli, DP; Citera, G; Lázaro, MA; Maldonado-Cocco, JA; Rosemffet, MG; Scheines, EJ, 2000) |
| "Melatonin improved mood, anxiety levels, and quality of life while decreasing cortisol levels in patients with fibromyalgia." | 7.91 | Melatonin Improves Mood Status and Quality of Life and Decreases Cortisol Levels in Fibromyalgia. ( Castaño, MY; Garrido, M; Gómez, MÁ; Rodríguez, AB, 2019) |
| "To assess urine levels of melatonin measured by 6-sulphatoxymelatonin (aMT6s) in patients with fibromyalgia (FM)." | 7.70 | Normal melatonin levels in patients with fibromyalgia syndrome. ( Abu-Shakra, M; Barak, R; Buskila, D; Neumann, L; Phillip, M; Press, J; Segev, Y, 1998) |
| "Fibromyalgia is a chronic syndrome characterized by widespread musculoskeletal pain and an extensive array of other symptoms including disordered sleep, fatigue, depression and anxiety." | 5.46 | Oral Supplementation of Melatonin Protects against Fibromyalgia-Related Skeletal Muscle Alterations in Reserpine-Induced Myalgia Rats. ( Bonomini, F; Favero, G; Lavazza, A; Rezzani, R; Rodella, LF; Stacchiotti, A; Trapletti, V, 2017) |
| "A systematic search of PubMed, Embase, and Scielo databases was performed, looking for articles on Melatonin and rheumatic diseases published between 1966 and August 2022." | 5.41 | Melatonin supplementation improves rheumatological disease activity: A systematic review. ( de Carvalho, JF; Skare, TL, 2023) |
| "Melatonin levels were measured by enzyme-linked immunosorbent assay." | 5.39 | Melatonin levels in premenopausal women with fibromyalgia syndrome. ( Baygutalp, F; Baykal, T; Erdal, A; Senel, K; Ugur, M, 2013) |
| "Fibromyalgia (FM) and chronic fatigue syndrome (CFS) are stress associated disorders mainly affecting women." | 5.30 | Melatonin levels in women with fibromyalgia and chronic fatigue syndrome. ( Brucksch, C; Crofford, L; Demitrack, MA; Engelberg, NC; Haus, E; Korszun, A; Masterson, L; Papadopoulos, E; Sackett-Lundeen, L, 1999) |
| " Melatonin can improve sleep quality, pain and pain threshold." | 5.19 | Melatonin analgesia is associated with improvement of the descending endogenous pain-modulating system in fibromyalgia: a phase II, randomized, double-dummy, controlled trial. ( Caumo, W; de Souza, IC; de Zanette, SA; Deitos, A; Laste, G; Machado, CB; Rozisky, JR; Schwertner, A; Torres, IL; Vercelino, R; Xavier, F, 2014) |
| "The aim of the study was to determine the possible effect of melatonin treatment on disturbed sleep, fatigue and pain symptoms observed in fibromyalgia (FM) patients." | 5.09 | The effect of melatonin in patients with fibromyalgia: a pilot study. ( Arias, MA; Brusco, LI; Cardinalli, DP; Citera, G; Lázaro, MA; Maldonado-Cocco, JA; Rosemffet, MG; Scheines, EJ, 2000) |
| "Melatonin improved mood, anxiety levels, and quality of life while decreasing cortisol levels in patients with fibromyalgia." | 3.91 | Melatonin Improves Mood Status and Quality of Life and Decreases Cortisol Levels in Fibromyalgia. ( Castaño, MY; Garrido, M; Gómez, MÁ; Rodríguez, AB, 2019) |
| "To assess urinary 6-sulphatoxymelatonin levels in a large consecutive series of patients with migraine and several comorbidities (chronic fatigue, fibromyalgia, insomnia, anxiety, and depression) as compared with controls." | 3.76 | Urinary 6-sulphatoxymelatonin levels are depressed in chronic migraine and several comorbidities. ( Cipolla-Neto, J; de Souza Vieira, DS; Lin, J; Masruha, MR; Minett, TS; Peres, MF; Vilanova, LC; Zukerman, E, 2010) |
| "To assess urine levels of melatonin measured by 6-sulphatoxymelatonin (aMT6s) in patients with fibromyalgia (FM)." | 3.70 | Normal melatonin levels in patients with fibromyalgia syndrome. ( Abu-Shakra, M; Barak, R; Buskila, D; Neumann, L; Phillip, M; Press, J; Segev, Y, 1998) |
| "Fibromyalgia is a chronic widespread pain condition affecting millions of people worldwide." | 2.58 | Combination pharmacotherapy for the treatment of fibromyalgia in adults. ( Gilron, I; Moore, RA; Shum, B; Thorpe, J; Wiffen, PJ, 2018) |
| "Fibromyalgia is a clinically well-defined chronic condition with a biopsychosocial aetiology." | 2.52 | Selective serotonin reuptake inhibitors for fibromyalgia syndrome. ( Cantrell, SE; Häuser, W; Nishishinya, MB; Urrútia, G; Walitt, B, 2015) |
| "Pain is a multidimensional response involving several levels of expression ranging from somatosensory to emotional." | 2.50 | Restless legs syndrome and pain disorders: what's in common? ( Delgado Rodrigues, RN; Goulart, LI; Prieto Peres, MF, 2014) |
| "Melatonin is an endogenous indoleamine, produced mainly by the pineal gland." | 2.47 | Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies. ( Amirian, I; Gögenur, I; Reiter, RJ; Rosenberg, J; Wilhelmsen, M, 2011) |
| "Fibromyalgia has gender, age and probably hormonal associations." | 2.43 | Menopause related sleep disorders. ( Eichling, PS; Sahni, J, 2005) |
| "Fibromyalgia is a chronic syndrome characterized by widespread musculoskeletal pain and an extensive array of other symptoms including disordered sleep, fatigue, depression and anxiety." | 1.46 | Oral Supplementation of Melatonin Protects against Fibromyalgia-Related Skeletal Muscle Alterations in Reserpine-Induced Myalgia Rats. ( Bonomini, F; Favero, G; Lavazza, A; Rezzani, R; Rodella, LF; Stacchiotti, A; Trapletti, V, 2017) |
| "Melatonin levels were measured by enzyme-linked immunosorbent assay." | 1.39 | Melatonin levels in premenopausal women with fibromyalgia syndrome. ( Baygutalp, F; Baykal, T; Erdal, A; Senel, K; Ugur, M, 2013) |
| "Fibromyalgia (FM) and chronic fatigue syndrome (CFS) are stress associated disorders mainly affecting women." | 1.30 | Melatonin levels in women with fibromyalgia and chronic fatigue syndrome. ( Brucksch, C; Crofford, L; Demitrack, MA; Engelberg, NC; Haus, E; Korszun, A; Masterson, L; Papadopoulos, E; Sackett-Lundeen, L, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (15.38) | 18.2507 |
| 2000's | 8 (30.77) | 29.6817 |
| 2010's | 12 (46.15) | 24.3611 |
| 2020's | 2 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| de Carvalho, JF | 1 |
| Skare, TL | 1 |
| Hemati, K | 1 |
| Amini Kadijani, A | 1 |
| Sayehmiri, F | 1 |
| Mehrzadi, S | 1 |
| Zabihiyeganeh, M | 1 |
| Hosseinzadeh, A | 1 |
| Mirzaei, A | 1 |
| Favero, G | 2 |
| Trapletti, V | 1 |
| Bonomini, F | 2 |
| Stacchiotti, A | 1 |
| Lavazza, A | 1 |
| Rodella, LF | 1 |
| Rezzani, R | 2 |
| Thorpe, J | 1 |
| Shum, B | 1 |
| Moore, RA | 1 |
| Wiffen, PJ | 1 |
| Gilron, I | 1 |
| Castaño, MY | 1 |
| Garrido, M | 1 |
| Rodríguez, AB | 1 |
| Gómez, MÁ | 1 |
| Franco, C | 1 |
| de Zanette, SA | 1 |
| Vercelino, R | 1 |
| Laste, G | 1 |
| Rozisky, JR | 1 |
| Schwertner, A | 1 |
| Machado, CB | 1 |
| Xavier, F | 1 |
| de Souza, IC | 1 |
| Deitos, A | 1 |
| Torres, IL | 1 |
| Caumo, W | 1 |
| Goulart, LI | 1 |
| Delgado Rodrigues, RN | 1 |
| Prieto Peres, MF | 1 |
| Walitt, B | 1 |
| Urrútia, G | 1 |
| Nishishinya, MB | 1 |
| Cantrell, SE | 1 |
| Häuser, W | 1 |
| Masruha, MR | 1 |
| Lin, J | 1 |
| de Souza Vieira, DS | 1 |
| Minett, TS | 1 |
| Cipolla-Neto, J | 1 |
| Zukerman, E | 1 |
| Vilanova, LC | 1 |
| Peres, MF | 1 |
| Hussain, SA | 1 |
| Al-Khalifa, II | 1 |
| Jasim, NA | 1 |
| Gorial, FI | 1 |
| Wilhelmsen, M | 1 |
| Amirian, I | 1 |
| Reiter, RJ | 3 |
| Rosenberg, J | 1 |
| Gögenur, I | 1 |
| Mahdi, AA | 1 |
| Fatima, G | 1 |
| Das, SK | 1 |
| Verma, NS | 1 |
| Senel, K | 1 |
| Baygutalp, F | 1 |
| Baykal, T | 1 |
| Erdal, A | 1 |
| Ugur, M | 1 |
| Acuna-Castroviejo, D | 2 |
| Escames, G | 1 |
| Eichling, PS | 1 |
| Sahni, J | 1 |
| Tan, DX | 1 |
| Press, J | 1 |
| Phillip, M | 1 |
| Neumann, L | 1 |
| Barak, R | 1 |
| Segev, Y | 1 |
| Abu-Shakra, M | 1 |
| Buskila, D | 1 |
| Webb, SM | 1 |
| Wikner, J | 1 |
| Hirsch, U | 1 |
| Wetterberg, L | 1 |
| Röjdmark, S | 1 |
| Korszun, A | 1 |
| Sackett-Lundeen, L | 1 |
| Papadopoulos, E | 1 |
| Brucksch, C | 1 |
| Masterson, L | 1 |
| Engelberg, NC | 1 |
| Haus, E | 1 |
| Demitrack, MA | 1 |
| Crofford, L | 1 |
| Citera, G | 1 |
| Arias, MA | 1 |
| Maldonado-Cocco, JA | 1 |
| Lázaro, MA | 1 |
| Rosemffet, MG | 1 |
| Brusco, LI | 1 |
| Scheines, EJ | 1 |
| Cardinalli, DP | 1 |
| Klerman, EB | 1 |
| Goldenberg, DL | 1 |
| Brown, EN | 1 |
| Maliszewski, AM | 1 |
| Adler, GK | 1 |
| Dauvilliers, Y | 1 |
| Touchon, J | 1 |
| Durlach, J | 1 |
| Pagès, N | 1 |
| Bac, P | 1 |
| Bara, M | 1 |
| Guiet-Bara, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase II Role of Immune-pineal Axis in Fibromyalgia: Noradrenergic Modulation and Chronotherapeutic Aspects[NCT02041455] | Phase 2/Phase 3 | 66 participants (Anticipated) | Interventional | 2010-06-30 | Recruiting | ||
| "Melatonin for Migraine Prevention in Adolescents: A Pilot Remote Trial: The BRAiN-M Study"[NCT02344316] | Phase 2 | 31 participants (Actual) | Interventional | 2015-05-31 | Completed | ||
| Melatonin for Adolescent Migraine Prevention Study (The MAP Study).[NCT03150797] | Phase 2 | 72 participants (Actual) | Interventional | 2017-08-02 | Terminated (stopped due to Insufficient Fund) | ||
| Effects of Perioperative Melatonin on Sleep, Pain, and Confusion After Joint Replacement Surgery[NCT01505465] | 50 participants (Actual) | Interventional | 2012-02-29 | Completed | |||
| Benefice Assessment of Repetitive Transcranial Magnetic Stimulation Used as an Additional Procedure to Rehabilitation Exercises in Patients Suffering From Fibromyalgia[NCT01308801] | 42 participants (Actual) | Interventional | 2011-04-30 | Completed | |||
| Evaluation of Spa Therapy in the Treatment of Fibromyalgia : a Randomized, Controlled, Open Multicenter Study[NCT02265029] | 220 participants (Actual) | Interventional | 2014-09-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Number of participants that had ≥85% headache diary compliance during weeks 12-16 of the study. (NCT02344316)
Timeframe: Weeks 12-16 of the study
| Intervention | Participants (Count of Participants) |
|---|---|
| Melatonin | 11 |
| Placebo | 10 |
eCAP tack caps will be used to measure medication adherence and the number of openings will be recorded per participant. (NCT02344316)
Timeframe: "during the At Home Active Study Period or Weeks 5-16"
| Intervention | Mean Number of Openings (Mean) |
|---|---|
| Melatonin | 39 |
| Placebo | 60 |
Number of Migraine/Migrainous Days Per 28 Day Period in melatonin group and placebo group as measured using an online/mobile device headache diary. (NCT02344316)
Timeframe: final 4 weeks of treatment
| Intervention | days (Mean) |
|---|---|
| Melatonin | 3.6 |
| Placebo | 4.9 |
Number of minutes to sleep onset as measured by a FitBit. (NCT02344316)
Timeframe: 16 weeks
| Intervention | minutes (Mean) |
|---|---|
| Melatonin | 15.2 |
| Placebo | 17.2 |
Change in mean migraine/migrainous days from weeks 5-8 of single-blind treatment phase to weeks 5-8 of randomized treatment phase for each group. (Medians reported when data were not normally distributed). (NCT03150797)
Timeframe: Weeks 5-8 of single-blind treatment phase to weeks 5-8 of randomized treatment phase.
| Intervention | days (Median) |
|---|---|
| Melatonin 3mg | 2 |
| Melatonin 6mg | -1 |
| Placebo Oral Capsule | 0 |
Mean CASQ score in weeks 5-8 of randomized treatment phase in melatonin treated group vs. placebo, and in each of the three pair-wise group comparisons. The CASQ is a 16-question instrument that uses Likert-like responses and has a score range from 16-80; higher scores indicate greater sleepiness (NCT03150797)
Timeframe: Weeks 5-8 of randomized treatment phase.
| Intervention | points (Mean) |
|---|---|
| Melatonin 3mg | 33 |
| Melatonin 6mg | 36 |
| Placebo Oral Capsule | 28 |
Mean migraine/migrainous days in weeks 5-8 of randomized treatment phase in melatonin 3 mg vs. placebo. (NCT03150797)
Timeframe: Weeks 5-8 of randomized treatment phase.
| Intervention | days (Median) |
|---|---|
| Melatonin 3mg | 2 |
| Melatonin 6mg | 2 |
| Placebo Oral Capsule | 2 |
Mean migraine/migrainous days in weeks 5-8 of randomized treatment phase in melatonin 6 mg vs. melatonin 3 mg. (NCT03150797)
Timeframe: Weeks 5-8 of randomized treatment phase.
| Intervention | days (Median) |
|---|---|
| Melatonin 3mg | 2 |
| Melatonin 6mg | 2 |
| Placebo Oral Capsule | 2 |
Mean migraine/migrainous days in weeks 5-8 of randomized treatment phase in melatonin 6 mg vs. placebo. (Medians reported when data were not normally distributed). (NCT03150797)
Timeframe: Weeks 5-8 of randomized treatment phase.
| Intervention | days (Median) |
|---|---|
| Melatonin 3mg | 2 |
| Melatonin 6mg | 2 |
| Placebo Oral Capsule | 2 |
Mean migraine/migrainous days in weeks 5-8 of randomized treatment phase in melatonin treated participants vs. placebo. (Ultimately, as the data were not normally distributed, medians were more appropriate). (NCT03150797)
Timeframe: weeks 5-8 of randomized treatment phase
| Intervention | days (Median) |
|---|---|
| Melatonin 3mg | 2 |
| Melatonin 6mg | 2 |
| Placebo Oral Capsule | 2 |
Number of days acute medication is used in weeks 5-8 of randomized treatment phase in melatonin treated group vs. placebo, and in each of the three pair-wise group comparisons. This refers to the number of days that medication for the acute treatment of headache was used during the time frame. (NCT03150797)
Timeframe: Weeks 5-8 of randomized treatment phase.
| Intervention | days (Median) |
|---|---|
| Melatonin 3mg | 5 |
| Melatonin 6mg | 3 |
| Placebo Oral Capsule | 3 |
Number of headache days in weeks 5-8 of randomized treatment phase in melatonin treated group vs. placebo, and in each of the three pair-wise group comparisons. This refers to number of headache days during the time period--regardless of whether they were migraine or not. (NCT03150797)
Timeframe: Weeks 5-8 of randomized treatment phase.
| Intervention | days (Median) |
|---|---|
| Melatonin 3mg | 8 |
| Melatonin 6mg | 4 |
| Placebo Oral Capsule | 5 |
Sleep time change from 96 hours before surgery to 72 hours after surgery (NCT01505465)
Timeframe: 96 hours before surgery to 72 hours after surgery
| Intervention | minutes (Mean) |
|---|---|
| Study: Melatonin | 20 |
| Control: Placebo | -55 |
11 reviews available for melatonin and Diffuse Myofascial Pain Syndrome
| Article | Year |
|---|---|
Melatonin supplementation improves rheumatological disease activity: A systematic review.
Topics: Arthritis, Rheumatoid; Dietary Supplements; Fibromyalgia; Humans; Melatonin; Osteoarthritis; Osteopo | 2023 |
Melatonin in the treatment of fibromyalgia symptoms: A systematic review.
Topics: Fatigue; Fibromyalgia; Humans; Melatonin; Pain; Randomized Controlled Trials as Topic | 2020 |
Combination pharmacotherapy for the treatment of fibromyalgia in adults.
Topics: 5-Hydroxytryptophan; Acetaminophen; Adult; Amitriptyline; Anti-Inflammatory Agents, Non-Steroidal; A | 2018 |
Restless legs syndrome and pain disorders: what's in common?
Topics: Calcium Channel Blockers; Diagnosis, Differential; Dopamine Agonists; Fibromyalgia; gamma-Aminobutyr | 2014 |
Selective serotonin reuptake inhibitors for fibromyalgia syndrome.
Topics: Amitriptyline; Citalopram; Fibromyalgia; Fluoxetine; Humans; Melatonin; Musculoskeletal Pain; Paroxe | 2015 |
Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies.
Topics: Analgesics; Animals; Disease Models, Animal; Fibromyalgia; Humans; Irritable Bowel Syndrome; Male; M | 2011 |
Abnormality of circadian rhythm of serum melatonin and other biochemical parameters in fibromyalgia syndrome.
Topics: Circadian Rhythm; Fibromyalgia; Humans; Melatonin; Syndrome | 2011 |
Menopause related sleep disorders.
Topics: Depression; Estrogen Replacement Therapy; Estrogens; Female; Fibromyalgia; Humans; Hydrocortisone; M | 2005 |
Melatonin therapy in fibromyalgia.
Topics: Female; Fibromyalgia; Humans; Male; Melatonin | 2007 |
[Sleep in fibromyalgia: review of clinical and polysomnographic data].
Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety; Arousal; Circadian Rhythm; Depression; Female; Fib | 2001 |
[Sleep in fibromyalgia: review of clinical and polysomnographic data].
Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety; Arousal; Circadian Rhythm; Depression; Female; Fib | 2001 |
[Sleep in fibromyalgia: review of clinical and polysomnographic data].
Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety; Arousal; Circadian Rhythm; Depression; Female; Fib | 2001 |
[Sleep in fibromyalgia: review of clinical and polysomnographic data].
Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety; Arousal; Circadian Rhythm; Depression; Female; Fib | 2001 |
Biorhythms and possible central regulation of magnesium status, phototherapy, darkness therapy and chronopathological forms of magnesium depletion.
Topics: Biological Clocks; Fatigue; Fibromyalgia; Humans; Light; Magnesium; Magnesium Deficiency; Melatonin; | 2002 |
3 trials available for melatonin and Diffuse Myofascial Pain Syndrome
| Article | Year |
|---|---|
Melatonin analgesia is associated with improvement of the descending endogenous pain-modulating system in fibromyalgia: a phase II, randomized, double-dummy, controlled trial.
Topics: Adolescent; Adult; Amitriptyline; Analgesics; Brain-Derived Neurotrophic Factor; Double-Blind Method | 2014 |
Adjuvant use of melatonin for treatment of fibromyalgia.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Drug Therapy, Combination; Female; Fibromyalgia; Fluox | 2011 |
The effect of melatonin in patients with fibromyalgia: a pilot study.
Topics: Administration, Oral; Adult; Aged; Anticonvulsants; Fatigue Syndrome, Chronic; Female; Fibromyalgia; | 2000 |
12 other studies available for melatonin and Diffuse Myofascial Pain Syndrome
| Article | Year |
|---|---|
Oral Supplementation of Melatonin Protects against Fibromyalgia-Related Skeletal Muscle Alterations in Reserpine-Induced Myalgia Rats.
Topics: Administration, Oral; Analysis of Variance; Animals; Antioxidants; Body Weight; Disease Models, Anim | 2017 |
Melatonin Improves Mood Status and Quality of Life and Decreases Cortisol Levels in Fibromyalgia.
Topics: Adult; Analgesics; Female; Fibromyalgia; Humans; Hydrocortisone; Male; Melatonin; Middle Aged; Mood | 2019 |
Mitochondrial Dysfunction in Skeletal Muscle of a Fibromyalgia Model: The Potential Benefits of Melatonin.
Topics: Animals; Biomarkers; Fibromyalgia; Locomotion; Male; Melatonin; Mitochondria; Models, Biological; Mu | 2019 |
Urinary 6-sulphatoxymelatonin levels are depressed in chronic migraine and several comorbidities.
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Biomarkers; Comorbidity; Depressive Disorder; Down-Regul | 2010 |
Urinary 6-sulphatoxymelatonin levels are depressed in chronic migraine and several comorbidities.
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Biomarkers; Comorbidity; Depressive Disorder; Down-Regul | 2010 |
Urinary 6-sulphatoxymelatonin levels are depressed in chronic migraine and several comorbidities.
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Biomarkers; Comorbidity; Depressive Disorder; Down-Regul | 2010 |
Urinary 6-sulphatoxymelatonin levels are depressed in chronic migraine and several comorbidities.
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Biomarkers; Comorbidity; Depressive Disorder; Down-Regul | 2010 |
Melatonin levels in premenopausal women with fibromyalgia syndrome.
Topics: Adult; Female; Fibromyalgia; Humans; Melatonin; Premenopause | 2013 |
Which alternative treatments work?
Topics: Back Pain; Chiropractic; Chondroitin; Cimicifuga; Complementary Therapies; Dietary Supplements; Echi | 2005 |
Melatonin therapy in fibromyalgia.
Topics: Adult; Female; Fibromyalgia; Humans; Male; Melatonin; Middle Aged | 2006 |
Normal melatonin levels in patients with fibromyalgia syndrome.
Topics: Adult; Female; Fibromyalgia; Humans; Melatonin; Middle Aged; Pain Measurement; Quality of Life; Refe | 1998 |
Fibromyalgia and melatonin: are they related?
Topics: Circadian Rhythm; Fibromyalgia; Humans; Insulin-Like Growth Factor I; Melatonin; Pineal Gland; Seaso | 1998 |
Fibromyalgia--a syndrome associated with decreased nocturnal melatonin secretion.
Topics: Adult; Biomarkers; Case-Control Studies; Circadian Rhythm; Female; Fibromyalgia; Humans; Melatonin; | 1998 |
Melatonin levels in women with fibromyalgia and chronic fatigue syndrome.
Topics: Adolescent; Adult; Circadian Rhythm; Fatigue Syndrome, Chronic; Female; Fibromyalgia; Humans; Hydroc | 1999 |
Circadian rhythms of women with fibromyalgia.
Topics: Adult; Body Temperature; Circadian Rhythm; Female; Fibromyalgia; Food; Humans; Hydrocortisone; Light | 2001 |